Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Sarcoma
2		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Connective and Soft Tissue
3		Interventions listed in this trial
			NY-ESO-1 peptide vaccine
			sargramostim
4		Sponsors listed in this trial
			Herbert Irving Comprehensive Cancer Center
			National Cancer Institute (NCI)